NAR Genomics and Bioinformatics Alderdice, M, Craig, S G, Humphries, M P, Gilmore, A, Johnston, N, Bingham, V, Coyle, V, Senevirathne, S, Longley, D B, Loughrey, M B, McQuaid, S, James, J A, Salto-Tellez, M, Lawler, M & McArt, D G 2021, ' Evolutionary genetic algorithm identifies IL2RB as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer ', NAR Genomics and Bioinformatics, vol. 3, no. 2, pp. lqab016 . https://doi.org/10.1093/nargab/lqab016
British Journal of Cancer Craig, S G, Humphries, M P, Allerdice, M, Bingham, V, Richman, S D, Loughrey, M B, Coleman, H G, Viratham-Pulsawatdi, A, McCombe, K, Murray, G I, Blake, A, Domingo, E, Domingo, E, Brown, L, Fisher, D, Seymour, M T, Quirke, P, Bankhead, P, McQuaid, S, Lawler, M, McArt, D G, Maughan, T, James, J A & Salto-Tellez, M 2020, ' Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia ', British Journal of Cancer . https://doi.org/10.1038/s41416-020-0985-5 Craig, S G, Humphries, M P, Alderdice, M, Bingham, V, Richman, S D, Loughrey, M B, Coleman, H G, Viratham-Pulsawatdi, A, McCombe, K, Murray, G I, Blake, A, Domingo, E, Robineau, J, Brown, L, Fisher, D, Seymour, M T, Quirke, P, Bankhead, P, McQuaid, S, Lawler, M, McArt, D G, Maughan, T S, James, J A & Salto-Tellez, M 2020, ' Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia ', British Journal of Cancer, vol. 123, no. 8, pp. 1280–1288 . https://doi.org/10.1038/s41416-020-0985-5 Queen's University Belfast-PURE
Oncotarget Dunne, P D, Coleman, H G, Bankhead, P, Alderdice, M, Gray, R T, McQuaid, S, Bingham, V, Loughrey, M B, James, J A, McCorry, A M B, Gilmore, A, Holohan, C, Klingbiel, D, Tejpar, S, Johnston, P G, McArt, D G, Nicolantonio, F D, Longley, D B & Lawler, M 2018, ' Bcl-xL as a poor prognostic biomarker and predictor of response to adjuvant chemotherapy specifically in BRAF-mutant stage II and III colon cancer ', Oncotarget, vol. 9, no. 17, pp. 13834-13847 . https://doi.org/10.18632/oncotarget.24481